Gene · 5699
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic models for musical rhythm perception and coordination. | Front Comput Neurosci | 2023 | 37265781 | PubTator, text mining | PubMed |
| Gastric cancer cell types display distinct proteasome/immunoproteasome patterns associated with migration and resistance to proteasome inhibitors. | J Cancer Res Clin Oncol | 2023 | 37261527 | PubTator, text mining | PubMed |
| PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production. | Sci Transl Med | 2023 | 37256937 | PubTator, text mining | PubMed |
| The dichotomous role of immunoproteasome in cancer: Friend or foe? | Acta Pharm Sin B | 2023 | 37250147 | PubTator, text mining | PubMed |
| Mitophagy restricts BAX/BAK-independent, Parkin-mediated apoptosis. | Sci Adv | 2023 | 37224250 | PubTator, text mining | PubMed |
| The first year of the COVID-19 pandemic in humanitarian settings: epidemiology, health service utilization, and health care seeking behavior in Bangui and surrounding areas, Central African Republic. | Confl Health | 2023 | 37210535 | PubTator, text mining | PubMed |
| Polyamine metabolism patterns characterized tumor microenvironment, prognosis, and response to immunotherapy in colorectal cancer. | Cancer Cell Int | 2023 | 37202800 | PubTator, text mining | PubMed |
| Genetic and epidemiological analyses of infection load and its relationship with psychiatric disorders. | Epidemiol Infect | 2023 | 37197974 | PubTator, text mining | PubMed |
| Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 | 37188783 | PubTator, text mining | PubMed |
| Multi-omics delineation of cytokine-induced endothelial inflammatory states. | Commun Biol | 2023 | 37188730 | PubTator, text mining | PubMed |
| Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma. | Sci Rep | 2023 | 37185612 | PubTator, text mining | PubMed |
| Immune landscape of breast tumors with low and intermediate estrogen receptor expression. | NPJ Breast Cancer | 2023 | 37179445 | PubTator, text mining | PubMed |
| Orthogonal approaches required to measure proteasome composition and activity in mammalian brain tissue. | J Biol Chem | 2023 | 37172721 | PubTator, text mining | PubMed |
| Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway. | Cell Rep | 2023 | 37171962 | PubTator, text mining | PubMed |
| The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer. | Nat Cancer | 2023 | 37127787 | PubTator, text mining | PubMed |
| The proteasome: A key modulator of nervous system function, brain aging, and neurodegenerative disease. | Front Cell Dev Biol | 2023 | 37123415 | PubTator, text mining | PubMed |
| Analysis of Nipah Virus Replication and Host Proteome Response Patterns in Differentiated Porcine Airway Epithelial Cells Cultured at the Air-Liquid Interface. | Viruses | 2023 | 37112941 | PubTator, text mining | PubMed |
| High-Throughput/High Content Imaging Screen Identifies Novel Small Molecule Inhibitors and Immunoproteasomes as Therapeutic Targets for Chordoma. | Pharmaceutics | 2023 | 37111759 | PubTator, text mining | PubMed |
| MK-886 protects against cardiac ischaemia/reperfusion injury by activating proteasome-Keap1-NRF2 signalling. | Redox Biol | 2023 | 37098317 | PubTator, text mining | PubMed |
| Prognostic association of immunoproteasome expression in solid tumours is governed by the immediate immune environment. | Mol Oncol | 2023 | 37097039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5699/papers?page=7